Single-stage, matrix-augmented autologous chondrocyte transplantation

AutoCart™ Procedure

Harness the benefits of viable, autologous tissue.

Support improved cartilage repair outcomes1 with the AutoCart procedure, which includes collecting and re-delivering autologous chondrocytes in a single procedure.

Watch Surgical Technique Animation
play_circle
See Scientific Support
south_east
GraftNet Autologous Tissue Collector

The AutoCart procedure is an efficient and cost-effective2 arthroscopic procedure that serves as a primary treatment option for defects that are contained.

Watch Technique
play_circle

For defects with subchondral bone damage, the AutoCart technique can be combined with a bone grafting procedure utilizing the OsteoAuger system for harvesting autologous cancellous bone in a fast and reproducible way.

Watch Technique
play_circle
GraftNet™ Device

Collect, Mix, Seal

OsteoAuger™ Bone Graft Harvesting System

OsteoAuger™ Bone Graft Harvesting System

add
PowerPick

PowerPick™ Instrument

add
GraftNet

GraftNet™ Autologous Tissue Collector

add
Arthrex ACP double syringe

Arthrex ACP® Double-Syringe System

add
Mixing and delivery system, Large Applicator

Mixing and Delivery System

add
Thrombinator

Thrombinator™ System

add

The AutoCart surgical technique uses the patient's own cells to create a high-quality scaffold for cartilage repair, in combination with the Thrombinator system to rapidly enhance the clotting cascade and produce a thrombin clot to seal the AutoCart graft into the defect, optimizing biologic potential.

A key component of the global AutoCart technique, the GraftNet device is designed to collect autologous tissue for a multitude of applications. Control the particulate size with the universal shaver attachment and make accessing autograft tissue as simple as Resect and Collect.

Take a closer look.

Hear From Leading Surgeons
play_circle

Scientific Support for the AutoCart™ Procedure

Compared to microfracture alone, single-stage autograft cartilage implantation provides superior patient outcomes and fewer negative outcomes associated with osteophyte formation.1 Additionally, the AutoCart procedure has shown a low reoperation rate and satisfactory patient-reported outcomes at 2 years.3,4

Autologous platelet‐rich plasma and fibrin‐augmented minced cartilage implantation in chondral lesions of the knee leads to good clinical and radiological outcomes after more than 12 months: A retrospective cohort study of 71 patients

Blanke F, Warth F, Oehler N, et al

open_in_new

Arthroscopic Autologous Minced Cartilage Implantation of Cartilage Defects in the Knee: A 2-Year Follow-up of 62 Patients

Schneider S, Ossendorff R, Walter SG, et al

open_in_new

Clinically significant outcomes following the treatment of focal cartilage defects of the knee…

Cole BJ, Haunschild ED, Carter T, et al

open_in_new

Comparison of minced cartilage implantation with autologous chondrocyte transplantation in an in vitro inflammation model

Ossendorff R, Grede L, Scheidt S, et al

open_in_new

Comparison of human articular cartilage tissue and chondrocytes isolated from peripheral versus central regions of traumatic lesions

Acevedo L, Iselin L, Berkelaar MHM, et al

open_in_new

Comparison of functional and radiographic outcomes of talar osteochondral lesions repaired with micronized allogenic cartilage extracellular matrix and bone marrow aspirate concentrate vs microfracture.

Drakos MC, Eble SK, Cabe TN, et al

open_in_new

Arthroscopic treatment of hip chondral defect with microfracture and platelet-rich plasma-infused micronized cartilage allograft augmentation.

Schallmo MS, Marquez-Lara A, Luo TD, Rosas S, Stubbs AJ

open_in_new

AutoCart Procedure Scientific Update

Arthrex, Inc.

open_in_new